DE102007061970A1 - Cosmetic, pharmaceutical or dermatological composition, useful for cosmetic and medical purposes, comprises copolymer, which is obtained through copolymerizing e.g. acrylamidoalkylsulfonic acid, comonomer, cross-linker and care components - Google Patents

Abstract

Cosmetic, pharmaceutical or dermatological composition (I) comprises: at least a copolymer, which is obtained through radically copolymerizing acrylamidoalkylsulfonic acid and their salts, optionally olefinically unsaturated, non-cationic, optionally cross-linked comonomer, optionally one or more mono- or polyunsaturated olefin, optionally cross-linked macromonomer, where the copolymerization takes place optionally in the presence of at least a polymer additive, greater than 0.5 wt.% of one or more cross-linker; and at least 10 wt.% of water-soluble care components for the skin and/or hairs. Cosmetic, pharmaceutical or dermatological composition (I) comprises: at least a copolymer, which is obtained through radically copolymerizing one or more acrylamidoalkylsulfonic acid and their salts, optionally one or more other olefinically unsaturated, non-cationic, optionally cross-linked comonomer exhibiting at least an oxygen-, nitrogen-, sulfur or phosphor-atom and contains a molecular weight of less than 500 g/mol, optionally one or more mono- or polyunsaturated olefin, optionally cross-linked macro-monomer containing at least an oxygen-, nitrogen-, sulfur or phosphorous-atom and exhibits a number average molecular weight of \- 200 g/mol, where the copolymerization takes place optionally in the presence of at least a polymer additive with a number average molecular weight of 200-10 9>g/mol, greater than 0.5 wt.% of one or more cross-linker, related to the total weight of the copolymer; and at least 10 wt.% of one or more water-soluble care components for the skin and/or hairs.

Description

The The present invention relates to cosmetic, pharmaceutical or dermatological compositions containing crosslinked water-soluble or water-swellable copolymers based on acrylamidoalkylsulfonic acids and / or their salts, characterized by a Vernetzeranteil greater than 0.5% by weight of the copolymer and at least one or more water-soluble care components in amounts by weight of at least 10%, based on the finished cosmetic, pharmaceutical or dermatological compositions, as well as their use for cosmetic and medical purposes. The invention cosmetic, pharmaceutical or dermatological compositions through a significantly improved moisturizing effect, good skin sensation and excellent rheological behavior out.

aim Skin care is the one caused by daily washing To balance the loss of fat and water in the skin, to protect the skin from the effects of the environment, especially from sun and wind, to protect a barrier against dirt, chemicals and microorganisms to create Loss of endogenous substances (eg water, natural Fats, electrolytes) counteract or compensate for this and delay skin aging.

cosmetic Skin care products should also have a clear appearance and have a favorable rheological behavior, toxicologically and ecotoxicologically safe and a pleasant skin feeling produce.

Water- or solvent-containing multicomponent systems such as emulsions or suspensions are often made from economic Reasons, for application reasons or for reasons of stability to higher viscosities set or thickened.

So can z. B. by increasing the viscosity of the external or internal phase of emulsions or suspensions, that the time to demixing the components of such System can be extended significantly, resulting in a Extension of the storage time makes noticeable. By increase The viscosity is even with many products whose uniform Spreadability improved, especially on uneven surfaces.

By more even distribution and prolonged Duration of action is thus increased the effectiveness. In addition to the mentioned application-related advantages offers the high Viscosity of such preparations also has other advantages in the production, packaging, filling and storage as well as during transport.

In The specialized literature will be a variety of different systems indicated to the rheological properties of aqueous or solvent-containing systems, emulsions, suspensions adjust. For example, cellulose ethers and others are known Cellulose derivatives (eg carboxymethylcellulose, hydroxyethylcellulose), Gelatin, starch and starch derivatives, sodium alginates, Fatty acid polyethylene glycol ester, agar-agar, tragacanth or Dextrins. As synthetic polymers, various materials are used Use, such. As polyvinyl alcohols, polyacrylamides, polyacrylic acid and various salts of polyacrylic acid, polyvinylpyrrolidone, Polyvinyl methyl ether, polyethylene oxides, copolymers of maleic anhydride and Vinyl methyl ether, as well as various mixtures and copolymers of the above compounds.

The However, compounds mentioned in the application show manifold Disadvantage. So z. As the cellulose derivatives or generally the based on natural resources and materials the resulting formulations very vulnerable against bacteria. From an application point of view, they mostly fall through education unpleasant, "stringy" gels on. Fettsäurepolyethylenglykolester tend to hydrolysis in the presence of water, the resulting insoluble fatty acids cause unwanted Opacities. Thickening agents of natural origin (eg agar-agar or tragacanth) show strongly varying depending on origin Composition on.

In EP 1 116 733 Water-soluble or water-swellable copolymers based on ammonium salts of acrylamidoalkylsulfonic acids and cyclic N-vinylcarboxamides or cyclic and linear N-vinylcarboxamides, their preparation and their use as thickeners, stabilizers of emulsions and dispersions are described.

In DE 100 65 047 and DE 100 65 046 are cosmetic or dermatological gel creams of the type Oil-in-water, or emulsions of the oil-in-water type, containing ammonium acryloyldimethyltaurate / vinylpyrrolidone copolymers described.

In WO 02/43689 discloses that hydrophobically modified comb polymers based on acryloyldimethyltaurine (AMPS ^®) - suitable for use both as a thickener, bodying agent, emulsifier, solubilizer, dispersant, lubricant, adhesive, conditioner and / or stabilizer - excellent for the formulation of cosmetic, pharmaceutical and dermatological Compositions are suitable.

In The mentioned writings are no references to formulations with very high levels of skin care components whose rheological Behavior and to find their sensory properties.

In WO 2004/032894 discloses cosmetic oil-in-water emulsions, the water-soluble copolymers based on monomers selected from (meth) acrylic acid, acrylamide, (meth) acrylic acid ester, N-vinylpyrrolidone having a crosslinker content of 0.005 to 0.5 wt .-%, based on the copolymer, as well as more than 10 wt .-% of a skin care component, in particular glycerol, based on the emulsion.

Some bring common skin care components as well as glycerin the disadvantage with it, especially at use levels above from 5% by weight, based on the finished skin care products, of a sticky one Cause skin sensation.

task It was, therefore, care products for the skin and for to develop the hair, which is high in water-soluble Care components included, a cheap and stable show rheological behavior and very good sensory properties for the skin and for the hair.

It It was surprisingly found that this task was solved is made by crosslinked water-soluble or water-swellable Copolymers based on acrylamidoalkylsulfonic acids or their salts, characterized by a crosslinker content of> 0.5 wt .-% relative on the copolymer, which is considered very good and stable thickener in formulations on aqueous, aqueous-alcoholic, aqueous-surfactant Base or in oil-in-water emulsions are suitable, very show good compatibility with skin care components and especially at the same time the skin feel of the compositions improve and significantly reduce the stickiness on the skin.

• I) mindestens ein Copolymer, erhältlich durch radikalische Copolymerisation von
• A) einer oder mehreren Acrylamidoalkylsulfonsäuren und/oder deren Salzen,
• B) gegebenenfalls einem oder mehreren weiteren olefinisch ungesättigten, nicht kationischen, gegebenenfalls vernetzenden, Comonomeren, die wenigstens ein Sauerstoff-, Stickstoff-, Schwefel- oder Phosphoratom aufweisen und ein Molekulargewicht kleiner 500 g/mol besitzen,
• C) gegebenenfalls einem oder mehreren einfach oder mehrfach olefinisch ungesättigten, gegebenenfalls vernetzenden, Makromonomeren, die jeweils mindestens ein Sauerstoff-, Stickstoff-, Schwefel- oder Phosphoratom besitzen und ein zahlenmittleres Molekulargewicht größer oder gleich 200 g/mol aufweisen,
• D) wobei die Copolymerisation gegebenenfalls in Gegenwart mindestens eines polymeren Additivs mit zahlenmittleren Molekulargewichten von 200 g/mol bis 10⁹ g/mol erfolgt, und
• E) > 0,5 Gew.-% eines oder mehrerer Vernetzer, bezogen auf das Gesamtgewicht des Copolymers, und
• II) mindestens 10 Gew.-% einer oder mehrerer wasserlöslicher Pflegekomponenten für die Haut und/oder für die Haare, bezogen auf die fertigen kosmetischen, pharmazeutischen und dermatologischen Zusammensetzungen.

The invention therefore cosmetic, pharmaceutical and dermatological compositions containing

• I) at least one copolymer obtainable by free-radical copolymerization of
• A) one or more acrylamidoalkylsulfonic acids and / or their salts,
• B) optionally one or more further olefinically unsaturated, non-cationic, optionally crosslinking, comonomers which have at least one oxygen, nitrogen, sulfur or phosphorus atom and have a molecular weight of less than 500 g / mol,
• C) optionally one or more mono- or poly-olefinically unsaturated, optionally crosslinking, macromonomers which each have at least one oxygen, nitrogen, sulfur or phosphorus atom and have a number-average molecular weight greater than or equal to 200 g / mol,
• D) wherein the copolymerization optionally in the presence of at least one polymeric additive having number average molecular weights of 200 g / mol to 10 ⁹ g / mol, and
• E)> 0.5 wt .-% of one or more crosslinkers, based on the total weight of the copolymer, and
• II) at least 10 wt .-% of one or more water-soluble care components for the skin and / or hair, based on the finished cosmetic, pharmaceutical and dermatological compositions.

The copolymers used according to the invention preferably have a molecular weight of from 10 ³ to 10 ⁹ g / mol, particularly preferably from 10 ⁴ to 10 ⁷ g / mol, particularly preferably from 5 × 10 ⁴ to 5 × 10 ⁶ g / mol.

Under the acrylamidoalkylsulfonic acids is 2-acrylamido-2-methylpropanesulfonic acid prefers.

at the acrylamidoalkyl sulfonates, d. H. the salts of acrylamidoalkylsulfonic acids, These may be the inorganic or organic salts of the acrylamidoalkylsulfonic acids act. It is preferably the salts of 2-acrylamido-2-methyl-propanesulfonic acid.

Preferred are the Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ and NH ₄ ⁺ salts, as well as the quaternary ammonium salts [HNR ¹ R ² R ³ ] ⁺ wherein R ¹ , R ² and R ^{3 are} independently the same or different and are hydrogen, a linear or branched alkyl group of 1 to 22 carbon atoms, a linear or branched, mono- or polyunsaturated alkenyl group of 2 to 22 carbon atoms, linear or branched Mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or a linear or branched mono-hydroxypropyl group, a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms or (EO) _n (PO) _m H, wherein EO is ethyleneoxy , PO is propyleneoxy, n is 0 to 30 and m is 0 to 30 and n + m ≥ 2.

In a preferred embodiment of the invention, the acrylamidoalkylsulfonic acids and / or their salts of component A) are selected from 2-acrylamido-2-methylpropanesulfonic acid and inorganic or organic salts of 2-acrylamido-2-methylpropanesulfonic acid, preferably from their Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , NH ₄ ⁺ salts, quaternary ammonium salts [HNR ¹ R ² R ³ ] ⁺ , wherein R ¹ , R ² and R ^{3 are} independently the same or different and are hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched mono- or polyunsaturated alkenyl group having 2 to 22 carbon atoms, a linear or branched mono-hydroxyalkyl group having 2 to 10 Carbon atoms, preferably a mono-hydroxyethyl or a linear or branched mono-hydroxypropyl group, a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms or (EO) _n (PO) _m H, wherein EO is ethyleneoxy, PO P ropylenoxy, n is 0 to 30 and m is 0 to 30 and n + m ≥ 2, may be.

In the case of the ammonium counterions, it may thus z. B. be monoalkylammonium, dialkylammonium or trialkylammonium counterions, wherein the alkyl groups independently z. B. (C ₁ -C ₂₂ ) alkyl radicals may be. The (C ₁ -C ₂₂ ) -alkyl radicals can, for. B. also be replaced by (C ₂ -C ₁₀ ) -Hydroxyalkylreste or it may be in the ammonium counterions z. B. also be monosubstituted to trisubstituted ethoxylated ammonium compounds with different degrees of ethoxylation.

Also Mixtures of two or more of the above representatives, d. H. Mixtures of different acrylamidoalkylsulfonic acids or from various salts of one or more acrylamidoalkylsulfonic acids, are within the meaning of the invention.

Of the Neutralization degree of Acrylamidoalkylsulfonsäuren can between 0 and 100%. A degree of neutralization is preferred from above 80%.

Based on the total weight of the copolymers is the content on acrylamidoalkylsulfonic acids or sulfonates at least 0.1 wt .-%, preferably 20 to 99.49 wt .-%, particularly preferably 50 to 98% by weight.

When Comonomers B) all olefinically unsaturated, not cationic monomers are used, their reaction parameters a copolymerization with acrylamidoalkylsulfonic acids or their salts in the respective reaction media allow. As comonomers B) are preferably unsaturated carboxylic acids and their anhydrides and salts, and their esters with aliphatic, olefinic, cycloaliphatic, arylaliphatic or aromatic Alcohols with a carbon number of 1 to 30. As unsaturated Carboxylic acids are particularly preferred are acrylic acid, Methacrylic acid, maleic acid, fumaric acid, Crotonic acid, itaconic acid and senecioic acid.

Of the Neutralization degree of the carboxylic acids can be between 0 and 100%.

When Comonomers B) furthermore preferred are open-chain N-vinylamides, preferably N-vinylformamide (VIFA), N-vinylmethylformamide, N-vinylmethylacetamide (VIMA) and N-vinylacetamide; cyclic N-vinylamides (N-vinyllactams) with a ring size of 3 to 9, preferably N-vinylpyrrolidone (NVP) and N-vinylcaprolactam; Amides of acrylic and methacrylic acid, preferably acrylamide, methacrylamide, N, N-dimethylacrylamide, N, N-diethylacrylamide and N, N-diisopropylacrylamide; alkoxylated acrylic and methacrylamides, preferably hydroxymethylmethacrylamide, hydroxyethylmethacrylamide, hydroxypropylmethacrylamide; Succinic acid mono- [2- (methacryloyloxy) ethyl ester], N, N-dimethylaminomethacrylate, diethylaminomethylmethacrylate, acrylic and methacrylamidoglycolic acid, 2- and 4-vinylpyridine, vinyl acetate, Methacrylic acid glycidyl ester, styrene, acrylonitrile, vinyl chloride, Stearyl acrylate, lauryl methacrylate, vinylidene chloride, tetrafluoroethylene, organic acids, their salts and esters, being as acids Vinylphosphonic acid, vinylsulfonic acid, allylphosphonic acid, Styrenesulfonic acid and Methallylsulfonsäure preferred are.

Preferred as counter ions of the salts of the comonomers B), for example the salts of the unsaturated carboxylic acids, are Li ⁺ , Na ⁺ , K ⁺ , Mg ^{+ +} , Ca ⁺⁺ , Al ⁺⁺⁺ , NH4 ⁺ , quaternary ammonium ions [HNR ¹ R ² R ³ ] ⁺ , wherein R ¹ , R ² and R ^{3 are} independently the same or different and are hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched, mono- or polyunsaturated alkenyl group having 2 to 22 carbon atoms, a linear or branched mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or a linear or branched mono-hydroxypropyl group, a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms, or (EO) _n (PO) _m H, wherein EO is ethyleneoxy, PO is propyleneoxy, n is 0 to 30 and m is 0 to 30 and n + m ≥ 2.

In the case of the ammonium counterions of the salts of the comonomers B), it may thus in turn z. B. be monoalkylammonium, dialkylammonium or trialkylammonium counterions, wherein the alkyl groups independently z. B. (C ₁ -C ₂₂ ) alkyl radicals may be. Also in this case, the (C ₁ -C ₂₂ ) -alkyl radicals z. B. be replaced by (C ₂ -C ₁₀ ) -Hydroxyalkylreste or it may be in the ammonium counterions z. B. also be monosubstituted to trisubstituted ethoxylated ammonium compounds with different degrees of ethoxylation.

The Comonomers of component B), however, do not include those under component A) listed acrylamidoalkylsulfonic acids or their salts. In a preferred embodiment of the invention the comonomers of component B) are compounds with discrete molecular weight.

Of the Weight fraction of comonomers B), based on the total mass of Copolymers, may be 0 to 99.39 wt .-% and is preferably 0.5 to 80 wt .-%, particularly preferably 2 to 50 wt .-%.

at the macromonomer C) is at least simply olefinic functionalized polymers with one or more discrete repeating units and a number average molecular weight greater or equal to 200 g / mol. In the copolymerization can also mixtures of chemically different macromonomers C) used become. The macromonomers are polymeric structures that are constructed from one or more repeating unit (s) and a characteristic of polymers molecular weight distribution exhibit.

worin
R¹, R², R³ und R⁴ unabhängig voneinander Wasserstoff oder n-aliphatische, iso-aliphatische, olefinische, cycloaliphatische, arylaliphatische oder aromatische (C₁-C₃₀)-Kohlenwasserstoffreste bedeuten,
Y für O, S, NH, PH steht, und
v und w die stöchiometrischen Koeffizienten betreffend die Ethylenoxideinheiten (EO) und Propylenoxideinheiten (PO) sind, wobei v und w unabhängig voneinander für eine Zahl von 0 bis 500, vorzugsweise 0 bis 30 stehen und die Summe aus v und w im Mittel ≥ 1 sein muss und die Verteilung der EO- und PO-Einheiten über die Makromonomerkette statistisch, blockartig, alternierend oder gradientenartig sein kann.Preferred as macromonomers C) are compounds according to formula (1)

wherein
R ¹ , R ² , R ³ and R ⁴ independently of one another denote hydrogen or n-aliphatic, iso-aliphatic, olefinic, cycloaliphatic, arylaliphatic or aromatic (C ₁ -C ₃₀ ) -hydrocarbon radicals,
Y stands for O, S, NH, PH, and
v and w are the stoichiometric coefficients concerning the ethylene oxide units (EO) and propylene oxide units (PO), where v and w independently represent a number from 0 to 500, preferably 0 to 30, and the sum of v and w averages ≥1 and the distribution of EO and PO units across the macromonomer chain may be random, block, alternating or gradient.

The macromonomers of component C) are particularly preferably selected from one or more compounds of the formula (1) in which
R ¹ , R ² and R ³ independently of one another denote hydrogen or methyl,
R ^{4 is} a linear or branched, saturated or unsaturated aliphatic hydrocarbon radical having 8 to 22 carbon atoms,
Y is O, S, NH or PH, preferably O, and
v and w independently represent a number from 0 to 50, preferably 0 to 30, where the sum of v and w must be on average ≥ 1 and the distribution of the EO and PO units via the macromonomer chain random, block-like, alternating or gradient-like.

Particularly preferred are the macromonomers of component C) selected from one or a plurality of compounds according to the formula (1), wherein
R ¹ , R ² and R ³ independently of one another denote hydrogen or methyl,
R ^{4 is} a linear or branched, saturated or unsaturated aliphatic hydrocarbon radical having 8 to 22 carbon atoms,
Y is O, S, NH or PH, preferably O, and
v is a number from 1 to 50, preferably from 2 to 30, and w is the number 0.

Exceptionally preferred macromonomers of component C) are summarized in Table 1 below. These are special compounds of formula (1). Table 1 Extraordinary Preferred Macromonomers of Formula (1) description R1 R2 R3 R4 V w ^® LA-030 methacrylate H H -CH ₃ lauryl 3 0 ^® LA-070 methacrylate H H -CH ₃ lauryl 7 0 ^® LA-200 methacrylate H H -CH ₃ lauryl 20 0 ^® LA-250 methacrylate H H -CH ₃ lauryl 25 0 ^® T-080 methacrylate H H -CH ₃ TALK 8th 0 ^® T-080 acrylate H H H TALK 8th 0 ^® T-250 methacrylate H H -CH ₃ TALK 25 0 ^® T-250 crotonate -CH ₃ H -CH ₃ TALK 25 0 ^® OC-030 methacrylate H H -CH ₃ octyl 3 0 ^® OC-105 methacrylate H H -CH ₃ octyl 10 5 ^® behenyl-010-methacrylate H H H -Behenyl 10 0 ^® behenyl-020-methacrylate H H H -Behenyl 20 0 ^® behenyl-025-methacrylate H H H -Behenyl 25 0 ^® behenyl-010-senecionate -CH ₃ -CH ₃ H -Behenyl 10 0 ^® PEG-440 diacrylate H H H -Acrylic 10 0 ^® B-11-50 methacrylate H H -CH ₃ butyl 17 13 ^® MPEG-750 methacrylate H H -CH ₃ -Methyl 18 0 ^® P-010 acrylate H H H phenyl 10 0 ^® O-050 acrylate H H H -Oleyl 5 0

Remain extraordinarily preferred macromonomers C) esters of acrylic acid or methacrylic acid with (C ₁₀ -C ₁₈₎ -Fettalkoholpolyglykolethern with 8 EO units (Genapol ^® C-080) C ₁₁ -Oxoalkoholpolyglykolethern with 8 EO units (Genapol UD-080 ^® ) (C ₁₂ -C ₁₄₎ -Fettalkoholpolyglykolethern (with 7 EO units (Genapol ^® LA-070) C ₁₂ -C ₁₄₎ -Fettalkoholpolyglykolethern with 11 EO units (Genapol ^® LA-110) (C ₁₆ -C ₁₈₎ -Fettalkoholpolyglykolethern with 8 EO units (Genapol ^® T-080) (C ₁₆ -C ₁₈₎ -Fettalkoholpolyglykolethern with 15 EO units (Genapol ^® T-150) (C ₁₆ -C ₁₈₎ -Fettalkoholpolyglykolethern (with 11 EO units Genapol ^® T-110) (C ₁₆ -C ₁₈₎ -Fettalkoholpolyglycolethern (with 20 EO units Genapol ^® T-200) (C ₁₆ -C ₁₈₎ -Fettalkoholpolyglycolethern (with 25 EO units Genapol ^® T-250) (C ₁₈ -C ₂₂ ) fatty alcohol polyglycol ethers having 25 EO units and / or iso (C ₁₆ -C ₁₈ ) fatty alcohol polyglycol ethers having 25 EO units.

The Genapol ^® grades there are products from Clariant.

The molecular weight of the macromonomers C) is preferably from 200 to 10 ⁶ g / mol, more preferably from 200 to 10 ⁴ g / mol, and more preferably from 200 to 5000 g / mol.

Based suitable total macromonomers may be the total weight of the copolymers C) are used in amounts up to 99.39 wt .-%. Preferably find the ranges 0.5 to 30 wt% and the ranges 70 to 99.39 Weight% application. Particularly preferred are the ranges from 1 to 20% by weight and from 75 to 95% by weight.

In a further preferred embodiment of the invention are the one or more copolymers of component I), which contained in the compositions of the invention are, by free radical copolymerization in the presence at least a polymeric additive of component D).

The polymeric additives of component D) differ from the Monomers of components A), B) and C) and the crosslinkers of Component E) in that they in contrast to the monomers mentioned or crosslinkers do not have polymerizable double bonds and therefore have a different mechanism in the in the compositions of the invention incorporated copolymers are incorporated. For this reason will be Also not in the context of the present invention as "monomers", but referred to as polymeric "additives".

Preferably the copolymerization is in the presence of at least one polymeric Additive D) carried out such that the additive D) before the actual copolymerization the polymerization or all-or partially dissolved is added. The use of several Additives D) is also according to the invention. networked Additives D) can also be used.

The Additives D) or their mixtures only have to be completely or partially soluble in the chosen polymerization medium be. During the actual polymerization step the additive D) has several functions. On the one hand, it prevents it in the actual polymerization step, the formation of overcrosslinked Polymer shares in the forming copolymer and on the other hand the additive D) according to the well-known Mechanism of graft copolymerization statistically of active Radicals attacked. This causes, depending on the additive D) more or less large portions thereof in the copolymers to be built in. In addition, suitable additives D) have the property the solution parameters of the forming copolymers during the radical polymerization reaction to change so that the average molecular weights to higher values be moved. Compared with analogous copolymers without the addition of additives D) are prepared, show those that were prepared with the addition of additives D), advantageously a significantly higher viscosity in aqueous Solution.

Prefers as additives D) are in water and / or alcohols, preferably in t-butanol, soluble homo- and copolymers. Under copolymers are also those with more than two different monomer types too understand.

Especially preferred as additives D) are homopolymers and copolymers of N-vinylformamide, N-vinylacetamide, N-vinylpyrrolidone, ethylene oxide, propylene oxide, acryloyldimethyltaurine, N-vinylcaprolactam, N-vinylmethylacetamide, acrylamide, acrylic acid, Methacrylic acid, N-vinylmorpholide, hydroxyethyl methacrylate, Diallyldimethylammonium chloride (DADMAC), [2- (methacryloyloxy) ethyl] trimethylammonium chloride, Acrylamidopropyltrimethylammonium chloride (APTAC), methacrylamidopropyltrimethylammonium chloride (MAPTAC); Polyalkylene glycols and / or alkyl polyglycols.

Particularly preferred additives D) are polyvinylpyrrolidones (z. B. Luviskol K15 ^{®, ®} K20 and K30 ^® from BASF), poly (N-vinylformamides), poly (N-vinylcaprolactams) and copolymers of N-vinylpyrrolidone, N-vinylformamide and or acrylic acid, which may also be partially or completely saponified.

The molecular weight of the additives D) is preferably from 10 ² to 10 ⁷ g / mol, more preferably from 0.2 × 10 ⁴ to 10 ⁶ g / mol.

The Use amount of the polymeric additive D), based to the total mass of the copolymer, 0 to 90 wt .-%, preferably 1 to 20 wt .-% and particularly preferably 1.5 to 10 wt .-%.

In another preferred embodiment of the invention are the one or more copolymers of component I), which contained in the compositions of the invention are, by radical copolymerization in the absence of a polymeric Additive of component D).

The Crosslinkers of component E) contain 2 or more radically polymerizable double bonds.

Preferred crosslinkers E) are methylenebisacrylamide; methylenebismethacrylamide; Esters of unsaturated mono- and polycarboxylic acids with polyols, preferably diacrylates, triacrylates, dimethacrylates and trimethacrylates, more preferably butanediol diacrylate, ethylene glycol diacrylate, butanediol dimethacrylate and ethyl glycol dimethacrylate, trimethylolpropane triacrylate (TMPTA) and trimethylolpropane trimethacrylate (TMPTMA); Allyl compounds, preferably allyl acrylate, allyl methacrylate, triallyl cyanurate, maleic diallyl esters, polyallyl esters, tetraallyloxyethane, triallylamine, tetraallylethylenediamine; Allyl esters of phosphoric acid and / or vinylphosphonic acid derivatives.

Especially preferred crosslinker is trimethylolpropane triacrylate (TMPTA) and methylenebisacrylamide (MBA).

The Use amount of the crosslinker E), based on the Total mass of the copolymer, 0.51 to 5 wt .-%, preferably 1 to 2.5 wt .-%, particularly preferably 1.2 to 2 wt .-%.

In a further preferred embodiment of the invention is the at least one copolymer of component I), which in the Contain compositions of the invention is, by radical copolymerization of compounds at least the components A), B) and E), preferably exactly the components A), B) and E) available.

• I) mindestens ein Copolymer, enthaltend A) 49,49 bis 98,49 Gew.-% der wiederkehrenden Struktureinheit der Formel (2)
  
  worin R⁵ Wasserstoff, Methyl oder Ethyl bedeutet, Z C₁-C₈-Alkylen bedeutet, und X für ein Alkali-, ein Erdalkali-, ein NH₄ ⁺-Ion oder ein [HNR¹R²R³]⁺-Ion steht, wobei R¹, R² und R³ unabhängig voneinander gleich oder verschieden sind und Wasserstoff, eine lineare oder verzweigte Alkylgruppe mit 1 bis 22 Kohlenstoffatomen, eine lineare oder verzweigte, einfach oder mehrfach ungesättigte Alkenylgruppe mit 2 bis 22 Kohlenstoffatomen, eine lineare oder verzweigte Mono-Hydroxyalkylgruppe mit 2 bis 10 Kohlenstoffatomen, bevorzugt eine Mono-Hydroxyethyl- oder eine lineare oder verzweigte Mono-Hydroxypropylgruppe, eine lineare oder verzweigte Di-Hydroxyalkylgruppe mit 3 bis 10 Kohlenstoffatomen oder (EO)_n(PO)_mH, worin EO Ethylenoxy, PO Propylenoxy, n 0 bis 30 und m 0 bis 30 bedeuten und n + m ≥ 2 ist, sein können, B1) 1 bis 50 Gew.-% der wiederkehrenden Struktureinheit der Formel (3)
  
  worin n eine ganze Zahl von 2 bis 9 bedeutet, und/oder B2) 1 bis 50 Gew.-% einer Mischung der wiederkehrenden Struktureinheit der Formel (3) und der wiederkehrenden Struktureinheit (4)
  
  worin R⁶, R⁷ und R⁸ unabhängig voneinander gleich oder verschieden sein können und Wasserstoff, eine lineare oder verzweigte Alkylgruppe mit jeweils 1 bis 30, bevorzugt 1 bis 20, besonders bevorzugt 1 bis 12 C-Atomen, oder eine lineare oder verzweigte ein- oder mehrfach ungesättigte Alkenylgruppe mit jeweils 2 bis 30, bevorzugt 2 bis 20, besonders bevorzugt 2 bis 12, C-Atomen, bedeuten, und E) 0,51 bis 5 Gew.-% vernetzende Strukturen, die aus Monomeren mit mindestens zwei olefinischen Doppelbindungen hervorgegangen sind und
• II) mindestens 10 Gew.-% einer oder mehrerer wasserlöslicher Hautpflegekomponenten, bezogen auf die fertigen Zusammensetzungen.

Particular preference is given to cosmetic, pharmaceutical and dermatological compositions according to the invention

• I) at least one copolymer comprising A) from 49.49 to 98.49% by weight of the repeating structural unit of the formula (2)
  
  wherein R ^{5 is} hydrogen, methyl or ethyl, Z is C ₁ -C ₈ alkylene, and X is an alkali, an alkaline earth, a NH ₄ ⁺ ion or a [HNR ¹ R ² R ³ ] ⁺ ion wherein R ¹ , R ² and R ^{3 are} independently the same or different and are hydrogen, a linear or branched alkyl group of 1 to 22 carbon atoms, a linear or branched, mono- or polyunsaturated alkenyl group of 2 to 22 carbon atoms, linear or branched Mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or a linear or branched mono-hydroxypropyl group, a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms or (EO) _n (PO) _m H, wherein EO is ethyleneoxy , PO is propyleneoxy, n is 0 to 30 and m is 0 to 30 and n + m ≥ 2, B1) 1 to 50% by weight of the repeating structural unit of the formula (3)
  
  where n is an integer from 2 to 9, and / or B2) from 1 to 50% by weight of a mixture of the repeating structural unit of the formula (3) and the repeating structural unit (4)
  
  wherein R ⁶ , R ⁷ and R ^{8 may} be the same or different independently and hydrogen, a linear or branched alkyl group having from 1 to 30, preferably 1 to 20, particularly preferably 1 to 12 C atoms, or a linear or branched one or polyunsaturated alkenyl group having in each case 2 to 30, preferably 2 to 20, particularly preferably 2 to 12, C atoms, and E) 0.51 to 5 wt .-% crosslinking structures consisting of monomers having at least two olefinic Double bonds have emerged and
• II) at least 10% by weight of one or more water-soluble skin care components, based on the finished compositions.

• I) mindestens ein Copolymer enthaltend 69,49 bis 97,49 Gew.-%, vorzugsweise 84,0 bis 96,0 Gew.-%, an Struktureinheiten der allgemeinen Formel (2), vorzugsweise abgeleitet vom Ammoniumsalz der 2-Acrylamido-2-methyl-propansulfonsäure, 2 bis 30 Gew.-%, vorzugsweise 3 bis 15 Gew.-%, an Struktureinheiten der allgemeinen Formel (3) bzw. (3) und (4), vorzugsweise abgeleitet von N-Vinylpyrrolidon, und 0,51 bis 5 Gew.-%, vorzugsweise 1 bis 2,5 Gew.-%, an vernetzenden Strukturen, die aus Monomeren mit mindestens zwei olefinischen Doppelbindungen hervorgegangen sind, wobei das Mischungsverhältnis der Mengen an Struktureinheiten der Formeln (3) und (4) innerhalb beliebiger Grenzen variieren kann, und
• II) mindestens 10 Gew.-% einer oder mehrerer wasserlöslicher Hautpflegekomponenten, bezogen auf die fertigen Zusammensetzungen.

Particular preference is given to cosmetic, pharmaceutical and dermatological compositions according to the invention

• I) at least one copolymer containing 69.49 to 97.49 wt .-%, preferably 84.0 to 96.0 wt .-%, of structural units of the general formula (2), preferably derived from the ammonium salt of 2-acrylamido-2 methylpropanesulfonic acid, 2 to 30% by weight, preferably 3 to 15% by weight, of structural units of the general formula (3) or (3) and (4), preferably derived from N-vinylpyrrolidone, and 0, From 51 to 5% by weight, preferably from 1 to 2.5% by weight, of crosslinking structures derived from monomers having at least two olefinic double bonds, the mixing ratio of the amounts of structural units of the formulas (3) and (4) can vary within any limits, and
• II) at least 10% by weight of one or more water-soluble skin care components, based on the finished compositions.

In a further preferred embodiment of the invention is the at least one copolymer of component I), which in the Contain compositions of the invention is, by radical copolymerization of compounds at least the components A), C) and E), preferably exactly the components A), C) and E) available.

• I) mindestens ein Copolymer, erhältlich durch Copolymerisation von A) 0,1 bis 99,39 Gew.-%, vorzugsweise 49,49 bis 95,39 Gew.-%, besonders bevorzugt 69,49 bis 90,39 Gew.-%, einer oder mehreren Acrylamidoalkylsulfonsäuren und/oder deren Salzen, C) 0,1 bis 99,39 Gew.-%, vorzugsweise 0,2 bis 50 Gew.-%, besonders bevorzugt 0,5 bis 30 Gew.-%, einem oder mehreren einfach oder mehrfach olefinisch ungesättigten, gegebenenfalls vernetzenden, Makromonomeren, die jeweils mindestens ein Sauerstoff-, Stickstoff-, Schwefel- oder Phosphoratom besitzen und ein zahlenmittleres Molekulargewicht größer oder gleich 200 g/mol aufweisen, und E) 0,51 bis 5 Gew.-% eines oder mehrerer Vernetzer, jeweils bezogen auf das Copolymer und
• II) mindestens 10 Gew.-% einer oder mehrerer wasserlöslicher Hautpflegekomponenten, bezogen auf die fertigen Zusammensetzungen.

Particular preference is given to cosmetic, pharmaceutical and dermatological compositions according to the invention

• I) at least one copolymer obtainable by copolymerization of A) from 0.1 to 99.39% by weight, preferably from 49.49 to 95.39% by weight, more preferably from 69.49 to 90.39% by weight , one or more acrylamidoalkylsulfonic acids and / or their salts, C) 0.1 to 99.39% by weight, preferably 0.2 to 50% by weight, particularly preferably 0.5 to 30% by weight, of one or more a plurality of mono- or poly-olefinically unsaturated, optionally crosslinking, macromonomers each having at least one oxygen, nitrogen, sulfur or phosphorus atom and a number average molecular weight greater than or equal to 200 g / mol, and E) 0.51 to 5 wt. -% of one or more crosslinkers, each based on the copolymer and
• II) at least 10% by weight of one or more water-soluble skin care components, based on the finished compositions.

The Cosmetic, pharmaceutical according to the invention and dermatological compositions contain the crosslinked ones Copolymers of component I) in amounts of preferably from 0.05 to 10 wt .-%, particularly preferably 0.1 to 5 wt .-%, particularly preferably 0.5 to 2 wt .-%, based on the finished compositions.

The preparation of the copolymers used according to the invention can be carried out in the in WO 02/43689 and in EP 1 116 733 done manner described.

water-soluble Care components according to component II) in Sense of the invention are preferably:

vitamins

• preferably selected from niacin, biotin, vitamin B2, Vitamin B3, Vitamin B6, Vitamin B3 derivatives (salts, acids, Esters, amides, alcohols), vitamin C, vitamin C derivatives (salts, Acids, esters, amides, alcohols), preferably as the sodium salt of the monophosphoric acid ester of ascorbic acid or as the magnesium salt of the phosphoric acid ester of ascorbic acid, Tocopherol and tocopherol acetate;

polyols

• preferably selected from glycols, polyalkylenepolyols, Alkylene polyols, propylene glycol, dipropylene glycol, polypropylene glycol, Polyethylene glycol, hexylene glycol, butylene glycol, neopentyl glycol, Sorbitol, hydroxypropyl sorbitol, erythritol, threitol, pentaerythritol, Xylitol, glucitol, mannitol, triols such as 1,2,6-hexanetriol, trimethylolpropane;

Glycerin, glycerin derivatives

• preferably selected from glycerol, ethoxylated Glycerin, propoxylated glycerol and mixtures thereof;

amino acids

• preferably selected from L-isomers of serine, Alanine, proline, hydroxyproline and D and L isomers of natural occurring amino acids;

Moisturizing agents

• preferably selected from the sodium salt of 2-pyrrolidone-5-carboxylate (NaPCA), guanidine; glycolic and their salts, lactic acid and its salts, glucosamine and their salts, lactamide monoethanolamine, acetamido monoethanolamine, Urea, hydroxy acids, preferably α- and β-hydroxy acids, particularly preferred α-hydroxy acids, panthenol and its derivatives, preferably D-panthenol (R-2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutamide), DL-panthenol, calcium pantothenate, panthetin, pantotheine, panthenylethyl ether;

Biogenic agents

• preferably selected from plant extracts, in particular Aloe Vera, local anesthetics, antibiotics, antiphlogistics, antiallergics, corticosteroids, sebostatics, bisabolol ^{®, ®} allantoin, phytantriol ^® and proteins;

silicones

• preferably selected from water-soluble silicone derivatives, in particular amino-substituted silicone derivatives, such as. B. Aminodimethicone and ethoxylated aminodimethicones available z. B. under the name SilCare ^® Silicone SEA (Clariant);

Polycationic compounds

• preferably selected from cationic polymers known by the INCl designation "Polyquaternium" and in particular Polyquaternium-31, Polyquaternium-16, Polyquaternium-24, Polyquaternium-7, Polyquaternium-22, Polyquaternium-39, Polyquaternium-28, Polyquaternium-2 , Polyquaternium-10, Polyquaternium-11, Polyquaternium 37 (and) mineral oil (and) PPG trideceth (Salcare ^® SC95), PVP dimethylaminoethyl methacrylate copolymer, Guarhydroxypropyltriammoniumchlorid, and calcium alginate and ammonium alginate contained.

Farther particularly preferred are cosmetic, containing pharmaceutical and dermatological compositions one or more water-soluble care components for the skin and / or the hair of component II) selected from glycerin, sorbitol, urea, niacinamides, panthenol, tocopherol acetate, Propylene glycol, erythritol and dipropylene glycol.

The cosmetic, pharmaceutical and dermatological compositions according to the invention comprise the abovementioned water-soluble skin and / or hair care components of component II), preferably in amounts of 10 to 40 wt .-%, particularly preferably from 12 to 30 wt .-% and particularly preferably from 15 to 25 wt .-%, based on the finished compositions.

The Cosmetic, pharmaceutical according to the invention and dermatological compositions have viscosities in the range of 500 to 300,000 mPa · s, preferably in the range from 1,000 to 250,000 mPa · s, and more preferably in the Range of 2,000 to 150,000 mPa · s and extraordinary preferably in the range of 3,000 to 100,000 mPa · s (25 ° C, Brookfield RVT, T-C spindle at 5 rpm).

preferred Embodiments of the invention Compositions are fluids, gels, oils, foams, Sprays, lotions, gel creams and creams.

The Cosmetic, pharmaceutical according to the invention and dermatological compositions are preferably aqueous Base, on a water-alcoholic basis or as an oil-in-water Emulsion before. Particularly preferred they are as emulsions of Type oil-in-water before.

• a) bis zu 89,95 Gew.-%, vorzugsweise 60 bis 89,95 Gew.-%, besonders bevorzugt 70 bis 87,75 Gew.-%, insbesondere bevorzugt 75 bis 84,95 Gew.-% einer Wasserphase,
• b) bis zu 60 Gew.-%, vorzugsweise 0,1 bis 40 Gew.-%, besonders bevorzugt 1 bis 30 Gew.-%, insbesondere bevorzugt 3 bis 20 Gew.-% und außerordentlich bevorzugt 5 bis 15 Gew.-% einer Ölphase,
• c) bis zu 15 Gew.-%, vorzugsweise 0,5 bis 12 Gew.-%, besonders bevorzugt 1 bis 8 Gew.-%, insbesondere bevorzugt 1 bis 5 Gew.-% eines oder mehrerer Emulgatoren und
• d) 0,05 bis 10 Gew.-%, vorzugsweise 0,1 bis 5 Gew.-%, besonders bevorzugt 0,5 bis 2 Gew.-%, an einem oder mehreren der oben beschriebenen Copolymeren.

In a particularly preferred embodiment, the compositions according to the invention are present as oil-in-water type emulsions, preferably as oil-in-water type cosmetic or dermatological emulsions, and are based on the total weight of the composition

• a) up to 89.95% by weight, preferably 60 to 89.95% by weight, particularly preferably 70 to 87.75% by weight, particularly preferably 75 to 84.95% by weight of a water phase,
• b) up to 60% by weight, preferably 0.1 to 40% by weight, more preferably 1 to 30% by weight, particularly preferably 3 to 20% by weight and most preferably 5 to 15% by weight an oil phase,
• c) up to 15 wt .-%, preferably 0.5 to 12 wt .-%, particularly preferably 1 to 8 wt .-%, particularly preferably 1 to 5 wt .-% of one or more emulsifiers and
• d) 0.05 to 10 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.5 to 2 wt .-%, of one or more of the copolymers described above.

• a) bis zu 89,95 Gew.-%, vorzugsweise 50 bis 89,95 Gew.-%, besonders bevorzugt 70 bis 87,95 Gew.-%, insbesondere bevorzugt 75 bis 84,95 Gew.-% einer Wasserphase,
• b) bis zu 60 Gew.-%, vorzugsweise 1 bis 30 Gew.-%, besonders bevorzugt 3 bis 25 Gew.-%, insbesondere bevorzugt 5 bis 15 Gew.-% einer Ölphase,
• c) 0,05 bis 10 Gew.-%, vorzugsweise 0,1 bis 5 Gew.-%, besonders bevorzugt 0,5 bis 2 Gew.-%, an einem oder mehreren der oben beschriebenen Copolymeren.

In a further particularly preferred embodiment, the compositions according to the invention are present as oil-in-water gel creams, preferably as oil-in-water cosmetic or dermatological gel creams, and contain based on the total weight of the composition

• a) up to 89.95% by weight, preferably 50 to 89.95% by weight, particularly preferably 70 to 87.95% by weight, particularly preferably 75 to 84.95% by weight of a water phase,
• b) up to 60% by weight, preferably 1 to 30% by weight, particularly preferably 3 to 25% by weight, particularly preferably 5 to 15% by weight of an oil phase,
• c) 0.05 to 10 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.5 to 2 wt .-%, of one or more of the copolymers described above.

For the compositions of the invention on aqueous-alcoholic or alcoholic base come all monohydric or polyhydric alcohols into consideration. Preference is given to alcohols having 1 to 4 carbon atoms such as ethanol, propanol, isopropanol, n-butanol, i-butanol, t-butanol or glycerol and alkylene glycols, in particular propylene, butylene or hexylene glycol, and mixtures of said alcohols. Further preferred alcohols are polyethylene glycols having a relative Molecular weight below 2,000. In particular, an insert of polyethylene glycol having a molecular weight between 200 and 600 and of polyethylene glycol with a relative Molecular weight between 400 and 600 is preferred.

The oil-in-water emulsions according to the invention may preferably contain as oil phase:
Hydrocarbon oils with linear or branched, saturated or unsaturated C ₇ -C ₄₀ -carbon chains, for example dodecane, isododecane, cholesterol, hydrogenated polyisobutylenes, docosans, hexadecane, isohexadecane, paraffins and isoparaffins, but also triglycerides of animal and vegetable origin, for example beef tallow, lard, Goose fat, perhydrosqualene, lanolin, sunflower, corn, soybean, rice, jojoba, babussu, pumpkin, grape seed, sesame, walnut, apricot, macadamia, avocado, sweet almond, meadowfoam , Castor oil, olive oil, peanut oil, rapeseed oil and coconut oil and synthetic oils such as purcellin oil, linear and / or branched fatty alcohols and fatty acid esters, preferably Guerbet alcohols having 6 to 18, preferably 8 to 10, carbon atoms; Esters of linear (C ₆ -C ₁₃ ) fatty acids with linear (C ₆ -C ₂₀ ) fatty alcohols; Esters of branched (C ₆ -C ₁₃ ) carboxylic acids with linear (C ₆ -C ₂₀ ) fatty alcohols, esters of linear (C ₆ -C ₁₈ ) fatty acids with branched alcohols, in particular 2-ethylhexanol; Esters of linear and / or branched fatty acids with polyhydric alcohols (such as, for example, dimerdiol or trimerdiol) and / or Guerbet alcohols; Alcohol esters of C ₁ -C ₁₀ -carboxylic acids or C ₂ -C ₃₀ -dicarboxylic acids, esters such as dioctyl adipate, diisopropyl dimer dilineloate; Propylene glycols / dicaprilat or waxes such as beeswax, paraffin wax or microwaxes, optionally in combination with hydrophilic waxes, such as. Cetylstearylal alcohol; Fluorinated and perfluorinated oils;
Monoglycerides of C ₁ -C ₃₀ -carboxylic acids, diglycerides of C ₁ -C ₃₀ -carboxylic acids, triglycerides of C ₁ -C ₃₀ -carboxylic acids, for example triglycerides of caprylic / capric acids, ethylene glycol monoesters of C ₁ -C ₃₀ -carboxylic acids, ethylene glycol diesters of C ₁ -C ₃₀ -carboxylic acids, propylene glycol monoesters of _C1-C30 carboxylic acids, propylene glycol diesters of C ₁ -C ₃₀ -carboxylic acids, and propoxylated and ethoxylated derivatives of the abovementioned classes of compound. The carboxylic acids may contain linear or branched alkyl groups or aromatic groups. Examples include diisopropyl, Diisopropyladipate, isopropyl palmitate, myristyl propionate, ethylene glycol, 2-ethylhexyl palmitate, isodecyl, di-2-ethylhexyl maleate, cetyl palmitate, myristyl myristate, stearyl stearate, cetyl stearate, behenyl, Dioctylmaleate, dioctyl, cetyl octanoate, dilinoleate diisopropyl, caprylic / caprylic, PEG-6 caprylic / capryl triglyceride, PEG-8 caprylic / capryl triglyceride, cetyl ricinoleate, cholesterol hydroxystearate, cholesterol isostearate, C ₁ -C ₃₀ monoesters and polyesters of glycerol, for example glyceryl tribehenate, glyceryl stearate, glyceryl palmitate, glyceryl distearate, glyceryl dipalmitate, C ₁ -C ₃₀ Carboxylic acid monoesters and polyesters of sugars, for example, glucose tetraoleate, glucose tetraesters of soybean oil fatty acid, mannose tetraesters of soybean oil fatty acid, galactose tetraesters of oleic acid, arabinoacetate esters of linoleic acid, xylose tetralinoleate, galactose pentaoleate, sorbitol tetraoleate, sorb itolhexaester of unsaturated soybean oil fatty acid, xylitol pentaoleate, sucrose tetraoleate, sucrose pentaoleate, sucrose hexaoleate, sucrose heptaoleate, sucrose oleate.

Of silicone oils are preferably available dimethylpolysiloxanes and cyclomethicones, polydialkylsiloxanes R ₃ SiO (R ₂ SiO) _x SiR ₃ , where R is methyl or ethyl, more preferably methyl, and x is a number from 2 to 500, for example, the dimethicones available from VICASIL (General Electric Company), Dow Corning 200, Dow Corning 225, Dow Corning Corporation (Dow Corning Corporation), trimethylsiloxy silicates [(CH ₂ ) ₃ SiO) _1,2 ] _x [SiO ₂ ] _y , wherein x is a number from 1 to 500 and y is a number from 1 to 500, dimethiconols R ₃ SiO [R ₂ SiO] _x SiR ₂ OH and HOR ₂ SiO [R ₂ SiO] _x SiR ₂ OH, where R is methyl or ethyl and x is a number up to 500, polyalkylaryl siloxanes, for example, the polymethylphenylsiloxanes, polydiarylsiloxanes, silicone resins, cyclin available under the trade designations SF 1075 METHYLPHENYL FLUID (General Electric Company) and 556 COSMETIC GRADE PHENYL TRIMETHICONE FLUID (Dow Corning Corporation) silicone silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine- and / or alkyl-modified silicone compounds, as well as polyethersiloxane copolymers, as well as alkyl-modified silicone fluids and silicone waxes, as described, for example, in US Pat. B. under the trade names SilCare ^® Silicone Clariant available.

The cosmetic compositions according to the invention can be used as further auxiliaries and additives surfactants, emulsifiers, cationic polymers, other thickeners, film-forming agents, antimicrobial Active ingredients, astringents, antioxidants, UV light protection filters, Pigments / micropigments, gelling agents and others in cosmetics common additives, such. Superfatting agents, Silicones, stabilizers, conditioners, preservatives, Pearlescing agents, dyes, fragrance and perfume oils, Solvents, opacifiers, fatty alcohols, substances with keratolytic and keratoplastic action or anti-dandruff agents, contain.

As anionic washing-active substances, ie anionic surfactants, are preferably mentioned:
C ₁₀ -C ₂₀ alkyl and alkylene carboxylates, alkyl ether carboxylates, fatty alcohol sulfates, fatty alcohol ether sulfates, alkyl amide sulfates and sulfonates, fatty acid alkylamide polyglycol ether sulfates, alkane sulfonates and hydroxyalkanesulfonates, olefinsulfonates, acyl esters of isethionates, α-sulfofatty acid esters, alkylbenzenesulfonates, alkylphenol glycol ether sulfonates, sulfosuccinates, sulfosuccinic monoesters and diesters , Fatty alcohol ether phosphates, protein-fatty acid condensation products, alkyl monoglyceride sulfates and sulfonates, alkyl glyceride ether sulfonates, fatty acid methyl taurides, fatty acid sarcosinates, sulforicinoleates, amphoacetates or glycinates, acylglutamates. These compounds and mixtures thereof are used in the form of their water-soluble or water-dispersible salts, for example the sodium, potassium, magnesium, ammonium, mono-, di- and triethanolammonium, and analogous alkylammonium salts.

The Amount of anionic surfactants is preferably 1 to 30 Wt .-%, particularly preferably 5 to 25 wt .-%, particularly preferably 10 to 22 wt .-%, based on the finished compositions.

Suitable cationic surfactants are, for example, quaternary ammonium salts such as di- (C ₁₀ -C ₂₄ -alkyl) -dimethylammonium chloride or bromide, preferably di- (C ₁₂ -C ₁₈ -alkyl) -dimethylammonium chloride or -bromide; C ₁₀ -C ₂₄ alkyl dimethylethyl ammonium chloride or bromide; C ₁₀ -C ₂₄ alkyl trimethyl ammonium chloride or bromide, preferably cetyl trimethyl ammonium chloride or bromide, and C ₂₀ -C ₂₂ alkyl trimethyl ammonium chloride or bromide; C ₁₀ -C ₂₄ alkyldimethylbenzylammonium chloride or bromide, preferably C ₁₂ -C ₁₈ alkyldimethylbenzylammonium chloride; N- (C ₁₀ -C ₁₈ alkyl) pyridinium chloride or bromide, preferably N- (C ₁₂ -C ₁₆ alkyl) pyridinium chloride or bromide; N- (C ₁₀ -C ₁₈ alkyl) isoquinolinium chloride, bro mid or monoalkyl sulfate; N- (C ₁₂ -C ₁₈ alkylpolyoylaminoformylmethyl) pyridinium chloride; N- (C ₁₂ -C ₁₈ alkyl) -N-methyl-morpholinium chloride, bromide or monoalkyl sulfate; N- (C ₁₂ -C ₁₈ alkyl) -N-ethyl-morpholinium chloride, bromide or monoalkyl sulfate; C ₁₆ -C ₁₈ -alkyl pentaoxethylammonium chloride; Diisobutylphenoxyethoxyethyldimethylbenzylammonium chloride; Salts of N, N-diethylaminoethylstearylamide and -oleylamide with hydrochloric acid, acetic acid, lactic acid, citric acid, phosphoric acid; N-acylaminoethyl-N, N-diethyl-N-methylammonium chloride, bromide or monoalkyl sulfate and N-acylaminoethyl-N, N-diethyl-N-benzyl-ammonium chloride, bromide or monoalkylsulfate, wherein acyl is preferably for Stearyl or oleyl.

The Amount of the cationic surfactants is preferably 0.1 to 10 wt .-%, particularly preferably 0.2 to 7 wt .-%, particularly preferably 0.5 to 5 wt .-% based on the finished compositions.

Suitable nonionic surfactants which can be used as detergent substances are preferably fatty alcohol ethoxylates (alkylpolyethylene glycols); Alkylphenolpolyethylenglykole; Alkylmercaptanpolyethylenglykole; Fatty amine ethoxylates (alkylaminopolyethylene glycols); Fatty acid ethoxylates (acyl polyethylene glycols); Polypropylenglykolethoxylate (Pluronics ^®); Fettsäureamidpolyethylenglykole; N-alkyl, N-alkoxy polyhydroxy fatty acid amides, especially fatty acid N-methylglucamides; Saccharoseester; polyglykolether; alkylpolyglycosides; Phosphoric acid esters (mono-, di- and triphosphoric esters ethoxylated and non-ethoxylated).

The Amount of nonionic surfactants in the inventive Compositions (eg in the case of rinse-off products) preferably in the range of 1 to 20 wt .-%, particularly preferably of 2 to 10 wt .-%, particularly preferably from 3 to 7 wt .-% based on the finished compositions.

Preferred amphoteric surfactants or amphoteric surfactants are: N- (C ₁₂ -C ₁₈ -alkyl) -β-aminopropionates and N- (C ₁₂ -C ₁₈ -alkyl) -β-iminodipropionates as alkali metal and mono-, di- and trialkylammonium salts; N-acylaminoalkyl-N, N-dimethyl-acetobetaine, preferably N- (C ₈ -C ₁₈ -acyl) aminopropyl-N, N-dimethylacetobetaine; C ₁₂ -C ₁₈ alkyl dimethyl sulfopropyl betaine; Amphoteric surfactants based on imidazoline (trade name: Miranol ^®, Steinapon® ^®), preferably the sodium salt of 1- (β-Carboxymethyloxyethyl) -1- (carboxymethyl) -2-lauryl-imidazoliniums; Amine oxides, e.g. C ₁₂ -C ₁₈ alkyl dimethyl amine oxide, fatty acid amidoalkyl dimethyl amine oxide.

The Amount of amphoteric surfactants is preferably from 0.5 to 20 wt .-%, particularly preferably from 1 to 10 wt .-%, based on the finished composition.

Of Further can in the inventive Composition foam-enhancing co-surfactants from the Group alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, Imidazolinium betaines and sulfobetaines, amine oxides and fatty acid alkanolamides or polyhydroxyamides are used.

preferred Surfactants in the compositions of the invention are alkyl ether sulfates, alkyl sulfates, in particular lauryl sulfate, Alkyl betaines, in particular cocoamidopropyl betaine, amphoacetates, Acylglutamates, especially sodium cocoylglutamate, alkylethersulfosuccinates, in particular di-sodium laurethsulfosuccinate and coconut fatty acid diethanolamide.

The Amount of in the compositions of the invention used surfactants is preferably from 1 to 70 Wt .-%, particularly preferably from 10 to 40 wt .-%, particularly preferably from 12 to 35 wt .-%, based on the finished compositions.

invention as emulsions present compositions can without be produced further emulsifier or also one or more emulsifiers contain.

In a further preferred embodiment of the invention are the compositions of the invention therefore free of emulsifiers. In another preferred embodiment The invention contains the invention Compositions, however, one or more emulsifiers.

These Emulsifiers can be selected from the group nonionic, anionic, cationic or amphoteric emulsifiers.

Suitable nonionic co-emulsifiers are preferably addition products of 0 to 30 mol of ethylene oxide and / or 0 to 5 mol of propylene oxide with linear fatty alcohols having 8 to 22 carbon atoms, with fatty acids having 12 to 22 carbon atoms, with alkylphenols with 8 up to 15 C atoms in the alkyl group and on sorbitan or sorbitol ester; (C ₁₂ -C ₁₈ ) fatty acid mono- and diesters of addition products of 0 to 30 moles of ethylene oxide with glycerol; Glycerol mono- and diesters and sorbitan mono- and diesters of saturated and unsaturated fatty acids having 6 to 22 carbon atoms and optionally their ethylene oxide addition products; Addition products of 15 to 60 moles of ethylene oxide with castor oil and / or hydrogenated castor oil; Polyol and in particular polyglycerol esters, such as. Polyglycerol polyricinoleate and polyglycerol poly-12-hydroxy stearate. Also preferably suitable are ethoxylated fatty amines, fatty acid amides, fatty acid alkanolamides and mixtures of compounds of several of these classes of substances.

When ionogenic co-emulsifiers are suitable for. B. anionic emulsifiers, such as mono-, di- or tri-phosphoric acid esters, soaps (e.g. As sodium stearate), fatty alcohol sulfates but also cationic emulsifiers such as mono-, di- and tri-alkyl quats and their polymeric derivatives.

At Amphoteric emulsifiers are preferably available Alkylaminoalkylcarboxylic acids, betaines, sulfobetaines and Imidazoline derivatives.

Farther can be naturally occurring emulsifiers, under beeswax, wool wax, lecithin and sterols are preferred, be used.

Preferably are fatty alcohol ethoxylates selected from the group of ethoxylated Stearyl alcohols, cetyl alcohols, Cetylstearylalkohole, in particular Polyethylene glycol (13) stearyl ether, polyethylene glycol (14) stearyl ether, Polyethylene glycol (15) stearyl ether, polyethylene glycol (16) stearyl ether, Polyethylene glycol (17) stearyl ether, polyethylene glycol (18) stearyl ether, Polyethylene glycol (19) stearyl ether, polyethylene glycol (20) stearyl ether, Polyethylene glycol (12) isostearyl ether, polyethylene glycol (13) isostearyl ether, Polyethylene glycol (14) isostearyl ether, polyethylene glycol (15) isostearyl ether, Polyethylene glycol (16) isostearyl ether, polyethylene glycol (17) isostearyl ether, Polyethylene glycol (18) isostearyl ether, polyethylene glycol (19) isostearyl ether, polyethylene glycol (20) isostearyl ether, Polyethylene glycol (13) cetyl ether, polyethylene glycol (14) cetyl ether, Polyethylene glycol (15) cetyl ether, polyethylene glycol (16) cetyl ether, Polyethylene glycol (17) cetyl ether, polyethylene glycol (18) cetyl ether, Polyethylene glycol (19) cetyl ether, polyethylene glycol (20) cetyl ether, Polyethylene glycol (13) isocetyl ether, polyethylene glycol (14) isocetyl ether, Polyethylene glycol (15) isocetyl ether, polyethylene glycol (16) isocetyl ether, Polyethylene glycol (17) isocetyl ether, polyethylene glycol (18) isocetyl ether, Polyethylene glycol (19) isocetyl ether, polyethylene glycol (20) isocetyl ether, Polyethylene glycol (12) oleyl ether, polyethylene glycol (13) oleyl ether, polyethylene glycol (14) oleyl ether, Polyethylene glycol (15) oleyl ether, polyethylene glycol (12) lauryl ether, Polyethylene glycol (12) isolauryl ether, polyethylene glycol (13) cetyl stearyl ether, Polyethylene glycol (14) cetyl stearyl ether, polyethylene glycol (15) cetyl stearyl ether, Polyethylene glycol (16) cetyl stearyl ether, polyethylene glycol (17) cetyl stearyl ether, Polyethylene glycol (18) cetyl stearyl ether, polyethylene glycol (19) cetyl stearyl ether.

When ethoxylated alkyl ether carboxylic acid or salts thereof Advantageously, the sodium laureth-13-carboxylate can be used.

When Ethoxylated alkyl ether sulfate is sodium laureth-14-sulfate, as ethoxylated cholesterol derivative polyethylene glycol (30) cholesteryl ether advantageous. Also preferred is polyethylene glycol (25) sojasterol.

When ethoxylated triglycerides may be advantageous in polyethylene glycol (60) Evening Primrose glycerides are used.

Farther it is advantageous to use the polyethylene glycol glycerin fatty acid esters from the group polyethylene glycol (20) glyceryl laurate, polyethylene glycol (6) glyceryl caprate / caprinate, Polyethylene glycol (20) glyceryl oleate, polyethylene glycol (20) glyceryl isostearate and to select polyethylene glycol (18) glyceryl oleate / cocoate.

Under The sorbitan esters are especially suitable for polyethylene glycol (20) sorbitan monolaurate, Polyethylene glycol (20) sorbitan monostearate, polyethylene glycol (20) sorbitan monoisostearate, Polyethylene glycol (20) sorbitan monopalmitate, polyethylene glycol (20) sorbitan monooleate.

Furthermore, the compositions of the invention may contain film formers which are selected depending on the application of salts of phenylbenzimidazole sulfonic acid, water-soluble polyurethanes, for example C ₁₀ -Polycarbamylpolyglycerylester, polyvinyl alcohol, Polyvinylpyrrolidoncopolymeren, for example vinylpyrrolidone / vinyl acetate copolymer, water-soluble acrylic acid polymers / copolymers or their esters or salts, for example Partialestercopolymere acrylic / methacrylic acid and polyethylene glycol ethers of fatty alcohols, such as acrylate / steareth-20-methacrylate copolymer, water-soluble cellulose, for example, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, water-soluble quaternary terniums, polyquaterniums, carboxyvinyl polymers, such as carbomers and salts thereof, polysaccharides, for example polydextrose and glucan, vinyl acetate / crotonate, 60 (Clariant) available for example under the trade name Aristoflex ^® A, and polymeric amine oxides, for example, under the trade names Diaformer Z-711 , 712, 731, 651, 632 available representatives.

The desired viscosity of the compositions can be adjusted by adding further thickening agents. In consideration preferably cellulose ethers and other cellulose derivatives (e.g., carboxymethylcellulose, hydroxyethylcellulose), gelatin, Starch and starch derivatives, sodium alginates, fatty acid polyethylene glycol esters, Agar-agar, tragacanth or dextrin derivatives, especially dextrin esters.

Further thickeners which may be considered are:
Metal salts of fatty acids, preferably having 12 to 22 carbon atoms, for example sodium stearate, sodium palmitate, sodium laurate, sodium arachidates, sodium behenate, potassium stearate, potassium palmitate, sodium myristate, aluminum monostearate, hydroxyfatty acids, for example 12-hydroxystearic acid, 16-hydroxyhexadecanoic acid; fatty acid amides; fatty acid; Dibenzal sorbitol and alcohol-soluble polyamides and polyacrylamides or mixtures thereof.

Prefers contain the compositions of the invention 0.01 to 20 wt .-%, particularly preferably 0.1 to 10 wt .-%, in particular preferably 1 to 8% by weight and very particularly preferably 3 to 7% by weight on gelling agents.

preferred Astringents are oxides, preferably magnesium oxide, aluminum oxide, Titanium dioxide, zirconium dioxide and zinc oxide, oxide hydrates, preferably alumina hydrate (Boehmite) and hydroxides, preferably of calcium, magnesium, Aluminum, titanium, zirconium or zinc.

The Contain compositions of the invention the astringent active ingredients preferably in amounts of 0 to 50 wt .-%, particularly preferably in amounts of 0.01 to 10 wt .-% and in particular preferably in amounts of 0.1 to 10 wt .-%.

The Compositions according to the invention can contain one or more antioxidants.

Preferred antioxidants are selected from amino acids (eg, glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazoles (eg, urocanic acid) and their derivatives, peptides such as DL-carnosine, D-carnosine, L-carnosine, and the like Derivatives (eg anserine), carotenoids, carotenes (eg α-carotene, β-carotene, lycopene) and derivatives thereof, chlorogenic acid and its derivatives, lipoic acid and derivatives thereof (eg dihydrolipoic acid), aurothioglucose, Propylthiouracil and other thiols (e.g., thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl , γ-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (eg esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (eg. Buthionine sulfoximines, homocysteine sulfoximine, buthione sulfones, penta -, hexa-, Heptathioninsulfoximin) in very low tolerated dosages, also (metal) -Chelatoren (z. Α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (eg citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (eg γ-linolenic acid, linoleic acid, oleic acid), folic acid and its derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (eg ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (e.g. B. Vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and Koniferylbenzoat the benzoin, rutinic acid and derivatives thereof, α-glycosylrutin, ferulic acid, furfurylidenglucitol, carnosine, butylhydroxytoluene, butylated hydroxyanisole, Nordihydroguajakharzsäure, Nordihydroguajaretsäure, trihydroxybutyrophenone, uric acid and their derivatives, mannose and their derivatives, zinc and its derivatives (eg ZnO, ZnSO ₄ ) selenium and its derivatives (eg selenium thionine), stilbenes and their derivatives (e.g. B. stilbene oxide, trans-stilbene), superoxide dismutase and the inventively suitable derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these substances.

The Antioxidants can protect the skin and hair from oxidative Protect stress. Preferred antioxidants are while vitamin E and its derivatives as well as vitamin A and its derivatives.

The Amount of the one or more antioxidants in the invention Compositions are preferably from 0.001 to 30% by weight, more preferably 0.05 to 20% by weight, and particularly preferably 1 to 10 wt .-%, based on the total weight of the composition.

Provided Vitamin E and / or derivatives thereof are the antioxidant (s), it is advantageous, their respective concentrations from the field from 0.001 to 10% by weight, based on the total weight of the compositions, to choose. If vitamin A, or vitamin A derivatives, or Carotenes or their derivatives represent the antioxidant (s), it is advantageous, their respective concentrations from the field from 0.001 to 10% by weight, based on the total weight of the compositions to choose.

The Compositions according to the invention can contain one or more UV filters. Suitable are 4-aminobenzoic acid, 3- (4'-trimethylammonium) benzylidene-boran-2-one methylsulfate, 3,3,5-trimethylcyclohexyl salicylate, 2-hydroxy-4-methoxybenzophenone, 2-phenylbenzimidazole-5-sulfonic acid and their potassium, sodium and triethanolamine salts, 3,3 '(1,4-phenylenedimethine) bis- (7,7-dimethyl-2-oxobicyclo [2.2.1] heptane-1-methanesulfonic acid and their salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) propane-1,3-dione, 3- (4'-sulfo) -benzyliden-bornan-2-one and its salts, 2-cyano-3,3-diphenyl-acrylic acid (2-ethylhexyl ester), Polymers of N- [2 (and 4) - (2-oxoborn-3-ylidenemethyl) benzyl] acrylamide, 4-Methoxy-cinnamic acid 2-ethylhexyl ester, ethoxylated ethyl 4-aminobenzoate, 4-methoxycinnamic acid isoamyl ester, 2,4,6-tris [p- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine, 2- (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3- (1,3,3,3-tetramethyl-1- (trimethylsilyloxy) -disiloxanyl) propyl) phenol, 4,4 '- [(6- [4 - ((1,1-dimethylethyl) -amino-carbonyl) phenylamino] -1,3,5-triazine-2,4-yl) diimino] bis (benzoic acid 2- ethylhexyl ester), 3- (4'-methylbenzylidene) -D, L-camphor, 3-benzylidene-camphor, 2-ethylhexyl salicylate, 4-Dimethylaminobenzoic acid 2-ethylhexyl ester, hydroxy-4-methoxy-benzophenone-5-sulfonic acid (Sulisobenzonum) and the sodium salt, 4-isopropylbenzyl salicylate, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) anilium methyl sulfate, Homosalates (INN) Oxybenzone (INN) 2-phenylbenzimidazole-5-sulfonic acid and their sodium, potassium, and triethanolamine salts, α- (2-oxoborn-3-ylidenes) toluene-4-sulfonic acid and their salts, octylmethoxycinnamic acid, isopentyl-4-methoxycinnamic acid, Isoamyl-p-methoxycinnamic acid, 2,4,6-trianilino (p-carbo-2'-ethylhexyl-1'-oxy) -1,3,5-triazines (Octyl triazone) phenol, 2-2 (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3- (1,3,3,3-tetramethyl-1- (trimethylsilyl) oxy) -disiloxanyl) propyl (Drometriazole trisiloxanes) benzoic acid, 4,4 - ((6- ((1,1-dimethylethyl) amino) carbonyl) phenyl) amino) -1,3,5-triazine-2,4-diyl) diimino) bis, bis (2-ethylhexyl) ester) benzoic acid, 4,4 - ((6 - ((((1,1-dimethylethyl) amino) carbonyl) phenyl) amino) -1,3,5-triazine-2,4-diyl) diimino) bis, bis (2) ethylhexyl) ester), 3- (4'-methylbenzylidene) -DL-camphor (4-methylbenzylidene camphor), 3-Benzylidene camphor (3-benzylidene camphor), 2-ethylhexyl salicylate (Octyl salicylate), 4-dimethylaminobenzoic acid, ethyl 2-hexyl ester (octyl dimethyl PABA), 2-hydroxy-4-methoxybenzo-phenone-5-sulfonic acid (Benzophenone-5) and the Na salt, 2,2'-methylene-bis-6- (2H-benzotriazol-2yl) -4- (tetramethyl-butyl) -1,1,3,3-phenol, Sodium salt of 2-2'-bis (1,4-phenylene) 1H-benzimidazole-4,6-disulfonic acid, (1,3,5) triazines-2,4-bis ((4- (2-ethyl-hexyloxy) -2-hydroxy) -phenyl) -6- (4-methoxyphenyl), 2-ethylhexyl-2-cyano-3,3-diphenyl-2-propenoate, glyceryl octanoate, Di-p-methoxycinnamic acid, p-aminobenzoic acid and their esters, 4-tert-butyl-4'-methoxydibenzoylmethane, 4- (2-β-glucopyranoxy) propoxy-2-hydroxybenzophenone, Octyl salicylate, methyl 2,5-diisopropyl cinnamic acid, cinoxate, Dihydroxy-dimethoxybenzophenone, disodium salt of 2,2'-dihydroxy-4,4'-dimethoxy-5,5'-disulfobenzophenone, Dihydroxybenzophenone, 1,3,4-dimethoxyphenyl-4,4-dimethyl-1,3-pentanedione, 2-ethylhexyl-dimethoxybenzylidenedioxoimidazolidine propionate, tetrahydroxybenzophenones, Terephthalylidenedicamphenesulfonic acid, 2,4,6-tris [4,2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine, Methylbis (trimethylsiloxy) silyl-isopentyltrimethoxycinnamic acid, Amyl p-dimethylaminobenzoate, amyl p-dimethylamino benzoate, 2-ethylhexyl p-dimethylaminobenzoate, Isopropyl-p-methoxycinnamic / Diisopropylzimtsäureester, 2-ethylhexyl-p-methoxycinnamic acid, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and the trihydrate, 2-hydroxy-4-methoxybenzophenone-5-sulfonate sodium salt and phenylbenzimidazole-sulfonic acid.

Further additives may be silicone compounds, preferably dimethylpolysiloxane, methylphenyl polysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine- and / or alkyl-modified silicone compounds, for example alkylsilicones SilCare ^® Silicone 41M10, SilCare ^® Silicone 41M15 , SilCare ^® Silicone 41M20, SilCare ^® Silicone 41M30 (Clariant), Alkyltrimethicone SilCare ^® 31M30, SilCare ^® 31M40, SilCare ^® 31M50, SilCare ^® 31M60 (Clariant), phenyltrimethicones SilCare ^® 15M30, SilCare ^® 15M40, SilCare ^® 15M50, SilCare ^® 15M60 (Clariant), polyalkylaryl siloxanes and polyethersiloxane copolymers.

The Compositions according to the invention can the above silicone compounds preferably in the amounts by weight from 0.1 to 20 wt .-%, particularly preferably 0.2 to 15 wt .-%, in particular preferably 0.5 to 10 wt .-% based on the finished compositions contain.

Cetyltrimethylammonium chloride, cetylpyridinium chloride, benzethonium chloride, diisobutylethoxyethyldimethylbenzylammonium chloride, sodium N-laurylsarcosinate, sodium N-palmethyl sarcosinate, lauroylsarcosine, N-myristoylglycine, potassium N-laurylsarcosine, trimethylammonium chloride, sodium aluminum chlorohydroxylactate, triethyl citrate, tricetylmethylammonium are particularly suitable as antimicrobial agents chloride, 2,4,4'-trichloro-2'-hydroxydiphenyl ether (triclosan), phenoxyethanol, 1,5-pentanediol, 1,6-hexanediol, 3,4,4'-trichlorocarbanilide (triclocarban), diaminoalkylamide, for example L- Lysine hexadecylamide, citrate heavy metal salts, salicylates, piroctose, in particular zinc salts, pyrithiones and their heavy metal salts, in particular Zn-pyrithiones, zinc phenol sulfate, farnesol and combinations of these active substances.

The Contain compositions of the invention the antimicrobial agents are preferred in amounts of up to 50% by weight, particularly preferably in amounts of 0.01 to 10 wt .-%, in particular preferably in amounts of 0.1 to 10 wt .-%, based on the finished Compositions.

As fungicidal active ingredients may preferably ketoconazole, oxiconazole, terbinafine, bifonazoles, butoconazole, cloconazole, clotrimazole, econazole, enilconazole, fenticonazole, isoconazole, miconazole, sulconazole, tioconazole fluconazole, itraconazole, terconazole, naftifine and terbinafine, Zn-pyrithione and Octopirox ^® in the Weight amounts of 0.05 to 5 wt .-%, preferably 0.1 to 3 wt .-%, particularly preferably 0.2 to 2 wt .-%, based on the finished compositions.

When Preservatives are preferably phenoxyethanol, Parabens, pentanediol or sorbic acid. They are preferably in amounts of 0.001 to 5 wt .-%, particularly preferably from 0.01 to 3 wt .-%, particularly preferably from 0.1 to 2 wt .-%, based on the finished compositions used.

As superfatting agent may preferably be lanolin and lecithin, not ethoxylated and polyethoxylated or acylated lanolin and lecithin derivatives, Polyol fatty acid esters, mono-, di- and triglycerides and / or fatty acid alkanolamides be used. As dyes, the for cosmetic and pharmaceutical purposes suitable and authorized Substances are used.

When Fragrance or perfume oils can be individual Fragrance compounds, eg. B. the synthetic products of the type the esters, ethers, aldehydes, ketones, alcohols and hydrocarbons be used. Fragrance compounds of the ester type are z. Benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, Linalyl acetate, dimethylbenzylcarbinylacetate, phenylethylacetate, Linalyl benzoate, benzyl formate, ethyl methyl phenyl glycinate, allyl cyclohexyl propionate, Styrallyl propionate and Benzylsalicylate. Count to the Ethern for example, benzyl ethyl ether, to the aldehydes z. B. the linear Alkanals of 8 to 18 C atoms, citral, citronellal, citronellyloxyacetaldehyde, Cyclamehaldehyde, Hydroxycitronellal, Lilial and Bourgeonal, too the ketones z. The ionones, alpha-isomethyl-ionone and methyl-cedryl-ketone, to the alcohols anethole, citronellol, eugenol, geraniol, linalol, Phenylethyl alcohol and terpineol belong to the hydrocarbons mainly the terpenes and balms. To be favoured Mixtures of different fragrances used together create an appealing scent.

perfume oils may also contain natural fragrance mixtures, as accessible from plant or animal sources are, for. Pine, citrus, jasmine, lily, rose, or ylang-ylang oil. Also essential oils of lower volatility, which are mostly used as aroma components, are suitable as Perfume oils, e.g. Sage oil, chamomile oil, Clove oil, lemon balm oil, mint oil, cinnamon leaf oil, Lime blossom oil, juniper berry oil, vetiver oil, Oliban oil, galbanum oil and ladanum oil.

When Acids or alkalis for pH adjustment are preferably Mineral acids, for example HCl, inorganic bases, For example, NaOH, KOH and organic acids are preferred Citric acid used.

The Compositions are preferably at a pH in the range 2 to 12, more preferably pH 3 to 8, adjusted.

Advantageous in the context of the invention is that the described Acryloyldimethyltaurinsäure-containing Copolymers also without co-use of an additional co-emulsifier and / or without the use of an additional bodybuilder can be used. The co-use of co-emulsifiers and / or consistency providers is therefore not mandatory, but possible. A combination with other known co-emulsifiers and / or consistency regulators can be used to set special cosmetic profiles and use synergistic effects would be desirable.

The nature of the compositions according to the invention is extremely advantageous:
The emulsions are creamy and ointment-free and do not have the gel-like or even gelatinous appearance of certain prior art emulsions in which the outer aqueous phase is thickened.

Also the cosmetic feeling on the skin is very good: at Applying the emulsion gives a feeling of freshness and comfort, while being rich and nourishing at the same time acts; she is soft and comfortable and in no way sticky.

The following examples and applications are intended to illustrate the invention without, however, limiting it to it (all percentages are by weight). Table 2 Examples I to IV ingredients I II III IV Water, deionized qs. qs. qs. qs. glycerin 20 20 20 20 niacinamide 5 5 5 5 panthenol 1 1 1 1 Isohexadecan 6 6 6 6 Ethylparaben 0.15 0.15 0.15 0.15 coconut oil 4 4 4 4 stearic acid 0.1 0.1 0.1 - Propylparaben 0.1 0.1 0.1 0.1 PEG-100 stearate 0.3 0.3 0.3 - stearyl 0.6 0.6 0.6 - cetyl alcohol 0.5 0.5 0.5 - behenyl 0.4 0.4 0.4 - tocopherol 0.5 0.5 0.5 0.5 petrolatum 2 2 2 2 Salcare ^® SC91 2 - - - Aristoflex® ^® AVC - 1 - 1 Aristoflex® ^® HMB - - 1 - NaOH 0.011 - - - Dry Flo Plus 2 2 2 - benzyl alcohol 0.25 0.25 0.25 0.25 Cyclopentasiloxane 1.5 1.5 1.5 1.5 Perfume 0.3 0.3 0.3 0.3 Viscosity [mPa.s] 25,000 22,000 25,000 30,000 PH value 5.5 5.5 5.5 5.5 Stability (90 days, 45 ° C) Phase separation after 35 days stable stable stable Stability (-5 ° C - 40 ° C, 5 cycles 24 h) creaming stable stable stable

As Table 2 is shown, are the inventive Compositions containing the described polymers constructed based on acrylamido-alkylsulfonic acids and high levels on care components (Examples II and III) more stable than compositions according to the prior art (Example I).

In addition, it has been found that compositions according to the invention are also stable without further addition of emulsifiers or stabilizers (Example IV). In addition, the compositions of the invention are characterized by a better skin feel and less stickiness. Chemical name of the commercial products used Salcare ^® SC91 Sodium Acrylate Copolymer and Paraffin Liquidum and PPG-1 Trideceth-6 Aristoflex® ^® AVC Ammonium acryloyldimethyltaurate / VP copolymer Aristoflex® ^® HMB Ammonium acryloyldimethyltaurate / beheneth-25 methacrylate crosspolymer Dry Flo Plus Aluminum Starch Octenylsuccinate niacinamide Vitamin B3

QUOTES INCLUDE IN THE DESCRIPTION

This list The documents listed by the applicant have been automated generated and is solely for better information recorded by the reader. The list is not part of the German Patent or utility model application. The DPMA takes over no liability for any errors or omissions.

Cited patent literature

• - EP 1116733 [0009, 0063]
• - DE 10065047 [0010]
• - DE 10065046 [0010]
• WO 02/43689 [0011, 0063]
• WO 2004/032894 [0013]

Claims (18)

Cosmetic, pharmaceutical or dermatological composition containing I) at least one copolymer obtainable by free-radical copolymerization of A) one or more acrylamidoalkylsulfonic acids and / or their salts, B) optionally one or more further olefinically unsaturated, non-cationic, optionally crosslinking, comonomers which at least one oxygen, nitrogen, sulfur or phosphorus atom and have a molecular weight of less than 500 g / mol, C) optionally one or more mono- or polyunsaturated, optionally crosslinking, macromonomers, each having at least one oxygen, nitrogen, D) wherein the copolymerization is optionally in the presence of at least one polymeric additive having number average molecular weights of 200 g / mol to 10 ⁹ g / mol; and E)> 0.5% by weight of one or more crosslinkers, based on the total weight of the copolymer, and II) at least 10% by weight of one or more water-soluble skin and / or hair care components, based on finished cosmetic, pharmaceutical or dermatological composition. A composition according to claim 1, characterized in that the acrylamidoalkylsulfonic acids and / or their salts of component A) are selected from 2-acrylamido-2-methyl-propanesulfonic acid and inorganic or organic salts of 2-acrylamido-2-methyl-propanesulfonic acid, preferably from their Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , NH ₄ ⁺ salts, quaternary ammonium salts [HNR ¹ R ² R ³ ] ⁺ , wherein R ¹ R ² and R ^{3 are} independently the same or different and are hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched mono- or polyunsaturated alkenyl group having 2 to 22 carbon atoms, a linear or branched mono-hydroxyalkyl group with 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or a linear or branched mono-hydroxypropyl group, a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms or (EO) _n (PO) _m H, wherein EO is ethylene noxy, PO propyleneoxy, n is 0 to 30 and m is 0 to 30 and n + m ≥ 2, may be. Composition according to Claim 1 or 2, characterized that the one or more comonomers of component B) is selected are made of open-chain N-vinylamides, preferably N-vinylformamide (VIFA), N-vinylmethylformamide, N-vinylmethylacetamide (VIMA) and N-vinylacetamide; cyclic N-vinylamides (N-vinyllactams) with a Ring size from 3 to 9, preferably N-vinylpyrrolidone (NVP) and N-vinylcaprolactam; Amides of acrylic and methacrylic acid, preferably acrylamide, methacrylamide, N, N-dimethylacrylamide, N, N-diethylacrylamide and N, N-diisopropylacrylamide; alkoxylated acrylic and methacrylamides, preferably hydroxymethylmethacrylamide, hydroxyethylmethacrylamide, hydroxypropylmethacrylamide; Succinic acid mono- [2- (methacryloyloxy) ethyl ester], N, N-dimethylaminomethacrylate, diethylaminomethylmethacrylate, acrylic and Methacrylamidoglycolic acid, 2- and 4-vinylpyridine, vinyl acetate, Methacrylic acid glycidyl ester, styrene, acrylonitrile, vinyl chloride, Stearyl acrylate, lauryl methacrylate, vinylidene chloride and / or tetrafluoroethylene, organic acids, their salts and esters, being as Acids vinylphosphonic acid, vinylsulphonic acid, Allylphosphonic acid, styrenesulfonic acid and methallylsulfonic acid are preferred. Composition according to one or more of claims 1 to 3, characterized in that the macromonomers of the component C) are selected from one or more compounds of the formula (1)

wherein R ¹ , R ² and R ³ independently of one another are hydrogen or methyl, R ^{4 is} a linear or branched, saturated or unsaturated aliphatic hydrocarbon radical having 8 to 22 carbon atoms, Y is O, S, NH or PH, preferably O, and v and w are independently of one another a number from 0 to 50, preferably 0 to 30, wherein the sum of v and w must be on average ≥ 1 and the distribution of EO and PO units across the macromonomer chain can be random, block, alternating or gradient. Composition according to Claim 4, characterized that v is a number from 1 to 50, preferably from 2 to 30, and w 0 is. Composition according to one or more of the claims 1 to 5, characterized in that the copolymer or copolymers radical copolymerization in the presence of at least one polymeric Additivs of component D) have been obtained. Composition according to Claim 6, characterized that the at least one polymeric additive of component D) is selected is made of homopolymers and copolymers of N-vinylformamide, N-vinylacetamide, N-vinylpyrrolidone, Ethylene oxide, propylene oxide, acryloyldimethyltaurine, N-vinylcaprolactam, N-vinylmethylacetamide, acrylamide, acrylic acid, Methacrylic acid, N-vinylmorpholide, hydroxyethyl methacrylate, Diallyldimethylammonium chloride (DADMAC), 12- (methacryloyloxy) ethyl] trimethylammonium chloride, Acrylamidopropyltrimethylammonium chloride (APTAC), methacrylamidopropyltrimethylammonium chloride (MAPTAC); Polyalkylene glycols and alkyl polyglycols. Composition according to one or more of the claims 1 to 5, characterized in that the copolymer or copolymers radical copolymerization in the absence of a polymeric additive of component D) have been obtained. Composition according to one or more of the claims 1 to 8, characterized in that the one or more Crosslinker E) are selected from methylenebisacrylamide (MBA), Methylenebismethacrylamide, esters of unsaturated mono- and Polycarboxylic acids with polyols, preferably diacrylates, triacrylates, dimethacrylates and trimethacrylates, more preferably butanediol diacrylate, ethylene glycol diacrylate, Butanediol dimethacrylate and ethylene glycol dimethacrylate, trimethylolpropane triacrylate (TMPTA) and trimethylolpropane trimethacrylate (TMPTMA); allyl compounds, preferably allyl acrylate, allyl methacrylate, triallyl cyanurate, maleic acid diallyl ester, Polyallylester, tetraallyloxyethane, triallylamine, tetraallylethylenediamine, Allyl esters of phosphoric acid and vinylphosphonic acid derivatives. Composition according to Claim 9, characterized that the one or more crosslinkers E) is selected are trimethylolpropane triacrylate (TMPTA) and methylenebisacrylamide (MBA). Composition according to one or more of the claims 1 to 10, characterized in that the at least one copolymer Component I) is obtainable by free-radical copolymerization of compounds of at least the components A), B) and E), preferably exactly the components A), B) and E). Composition according to one or more of the claims 1 to 10, characterized in that the at least one copolymer Component I) is obtainable by free-radical copolymerization of compounds of at least the components A), C) and E), preferably exactly the components A), C) and E). Composition according to one or more of the claims 1 to 12, characterized in that they are the at least one copolymer of component I) in amounts of 0.05 to 10 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.5 to 2 wt .-%, based on the finished composition contains. Composition according to one or more of the claims 1 to 13, characterized in that the one or more water-soluble care components for the skin and / or for the hair of component II) are made of glycerin, sorbitol, urea, niacinamides, panthenol, Tocopherol acetate, propylene glycol, erythritol and dipropylene glycol. Composition according to one or more of the claims 1 to 14, characterized in that they are the one or more water-soluble care components for the skin and / or for the hair of component II) in quantities of 10 to 40 wt .-%, preferably from 12 to 30 wt .-% and particularly preferably from 15 to 25 wt .-%, based on the finished composition contains. Composition according to one or more of the claims 1 to 15, characterized in that it is an emulsion of the oil-in-water type is present. Composition according to one or more of the claims 1 to 16, characterized in that they are free of emulsifiers. Composition according to one or more of the claims 1 to 16, characterized in that they contain one or more emulsifiers contain.